Skip to main content
Log in

Stereotaktisch geführte Radiotherapie beim lokal fortgeschrittenen hepatozellulären Karzinom

Gepoolte Analyse aus zwei Phase-I/II-Studien

Stereotactic body radiotherapy for the treatment of hepatocellular cancer

Pooled anaylsis of two phase I/II trials

  • Literatur kommentiert
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Tse RV, Hawkins M, Lockwood G et al (2008) Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol 26:657–664

    Article  PubMed  Google Scholar 

  2. Bujold A, Massey CA, Kim JJ et al (2013) Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. J Clin Oncol 31:1631–1639

    Article  PubMed  Google Scholar 

  3. Dawson LA, Eccles C, Craig T (2006) Individualized image guided iso-NTCP based liver cancer SBRT. Acta Oncol 45:856–864

    Article  PubMed  Google Scholar 

  4. Feng M, Ben-Josef E (2011) Radiation therapy for hepatocellular carcinoma. Semin Radiat Oncol 21:271–277

    Article  PubMed  Google Scholar 

  5. Mendez Romero A, Wunderink W, Hussain SM et al (2006) Stereotactic body radiation therapy for primary and metastatic liver tumors: a single institution phase i–ii study. Acta Oncol 45:831–837

    Article  Google Scholar 

  6. Cárdenes HR, Price TR, Perkins SM et al (2010) Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma. Clin Transl Oncol 12:218–225

    Article  PubMed  Google Scholar 

  7. Liang SX, Zhu XD, Xu ZY et al (2006) Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance. Int J Radiat Oncol Biol Phys 65:426–434

    Article  PubMed  Google Scholar 

  8. Xu ZY, Liang SX, Zhu J et al (2006) Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma. Int J Radiat Oncol Biol Phys 65:189–195

    Article  PubMed  Google Scholar 

  9. Skinner HD, Sharp HJ, Kaseb AO et al (2011) Radiation treatment outcomes for unresectable hepatocellular carcinoma. Acta Oncol 50:1191–1198

    Article  PubMed  Google Scholar 

  10. Andolino DL, Johnson CS, Maluccio M et al (2011) Stereotactic body radiotherapy for primary hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 81:e447–e453

    Article  PubMed  Google Scholar 

  11. Habermehl D, Debus J, Ganten T et al (2013) Hypofractionated carbon ion therapy delivered with scanned ion beams for patients with hepatocellular carcinoma – feasibility and clinical response. Radiat Oncol 8:59

    Article  PubMed  Google Scholar 

  12. Combs SE, Habermehl D, Ganten T et al (2011) Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: the PROMETHEUS-01 trial. BMC Cancer 11:67

    Article  PubMed  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. D. Habermehl und S.E. Combs geben an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to D. Habermehl or S.E. Combs.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Habermehl, D., Combs, S. Stereotaktisch geführte Radiotherapie beim lokal fortgeschrittenen hepatozellulären Karzinom. Strahlenther Onkol 189, 1051–1053 (2013). https://doi.org/10.1007/s00066-013-0449-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-013-0449-4

Navigation